Use of exercise testing in the evaluation of interventional efficacy: an official ERS statement

L Puente-Maestu, P Palange… - European …, 2016 - Eur Respiratory Soc
This document reviews 1) the measurement properties of commonly used exercise tests in
patients with chronic respiratory diseases and 2) published studies on their utilty and/or …

[图书][B] ACSM's guidelines for exercise testing and prescription

G Liguori, American College of Sports Medicine - 2020 - books.google.com
The flagship title from the prestigious American College of Sports Medicine, this critical
handbook delivers scientifically based, evidence-informed standards to prepare you for …

Combination bronchodilator therapy in the management of chronic obstructive pulmonary disease

DP Tashkin, GT Ferguson - Respiratory research, 2013 - Springer
Chronic obstructive pulmonary disease (COPD) represents a significant cause of global
morbidity and mortality, with a substantial economic impact. Recent changes in the Global …

Effect of bronchodilation, exercise training, and behavior modification on symptoms and physical activity in chronic obstructive pulmonary disease

T Troosters, F Maltais, N Leidy, KL Lavoie… - American Journal of …, 2018 - atsjournals.org
Rationale: Bronchodilation and exercise training (ExT) improve exercise tolerance in
patients with chronic obstructive pulmonary disease (COPD); however, behavior …

Responsiveness of various exercise‐testing protocols to therapeutic interventions in COPD

B Borel, S Provencher, D Saey… - Pulmonary medicine, 2013 - Wiley Online Library
Exercise intolerance is a key element in the pathophysiology and course of Chronic
Obstructive Pulmonary Disease (COPD). As such, evaluating exercise tolerance has …

Proposing a standardized method for evaluating patient report of the intensity of dyspnea during exercise testing in COPD

A Hareendran, NK Leidy, BU Monz… - … journal of chronic …, 2012 - Taylor & Francis
Background Measuring dyspnea intensity associated with exercise provides insights into
dyspnea-limited exercise capacity, and has been used to evaluate treatment outcomes for …

Alpha 1 antitrypsin to treat lung disease in alpha 1 antitrypsin deficiency: recent developments and clinical implications

KR Chapman, J Chorostowska-Wynimko… - … journal of chronic …, 2018 - Taylor & Francis
Alpha 1 antitrypsin deficiency is a hereditary condition characterized by low alpha 1
proteinase inhibitor (also known as alpha 1 antitrypsin [AAT]) serum levels. Reduced levels …

Long-acting bronchodilators improve exercise capacity in COPD patients: a systematic review and meta-analysis

F Di Marco, G Sotgiu, P Santus, DE O'Donnell… - Respiratory …, 2018 - Springer
Background We carried out a systematic review and meta-analysis with the aim to evaluate
the efficacy of long-acting bronchodilators on exercise capacity in COPD patients. Methods …

Effect of 12 weeks of once-daily tiotropium/olodaterol on exercise endurance during constant work-rate cycling and endurance shuttle walking in chronic obstructive …

F Maltais, D O'Donnell, JB Galdiz Iturri… - Therapeutic …, 2018 - journals.sagepub.com
Background: The TORRACTO® study evaluated the effects of tiotropium/olodaterol versus
placebo on endurance time during constant work-rate cycling and constant speed shuttle …

A‐kinase anchoring proteins: cAMP compartmentalization in neurodegenerative and obstructive pulmonary diseases

WJ Poppinga, P Muñoz‐Llancao… - British journal of …, 2014 - Wiley Online Library
The universal second messenger cAMP is generated upon stimulation of Gs protein‐
coupled receptors, such as the β2‐adreneoceptor, and leads to the activation of PKA, the …